Visual hallucinations in Parkinson's disease: Clues to separate origins

Journal of the Neurological Sciences

Volumn 248, Issue 1-2, 2006, Pages 143-150

  Onofrj, M ^a,b   Bonanni, L ^a,b   Albani, G ^c   Mauro, A ^c   Bulla, D ^d   Thomas, A ^a,b  

^a Movement Disorders Center   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Charles Bonnet Syndrome; Parkinson's Disease; Peduncular hallucinosis; REM sleep behaviour disorder; Virtual reality; Visual evoked potentials; Visual hallucinations

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; COGNITION; COGNITIVE DEFECT; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; FISHER EXACT TEST; GLOBUS PALLIDUS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MANTEL HAENSZEL TEST; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NONHUMAN; PARASOMNIA; PARKINSON DISEASE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REM SLEEP; SHY DRAGER SYNDROME; SLEEP DISORDER; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUBTHALAMIC NUCLEUS; VIRTUAL REALITY; VISION; VISUAL DISORDER; VISUAL HALLUCINATION;

ANTIPARKINSON AGENTS; EVOKED POTENTIALS, VISUAL; HALLUCINATIONS; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MODELS, BIOLOGICAL; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER;

EID: 33751032905     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.05.025     Document Type: Article

References (73)

1. Diederich N.J., Goetz C.G., and Stebbins G.T. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perception: focused review and a new integrative model. Mov Disord 20 2 (2005) 130-140
2. Saint-Cyr J.A., Taylor A.E., and Lang A.E. Procedural learning and neostriatal dysfunction in man. Brain 111 (1988) 941-956
3. Dolan R.J., Fletcher P., Frith C.D., Friston K.J., Frackowiak R.S., and Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulated cortex in schizophrenia. Nature 378 6553 (1995) 180-182
4. Swerdlow N.R., and Koob G.F. Dopamine, schizophrenia, mania and depression toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Res 10 (1987) 215-217
5. Korczyn A.D. Hallucinations in Parkinson's Disease. Lancet 29 (2001) 1031-1032
6. Doe de Maindreville A., Fénelon G., and Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 20 2 (2005) 212-217
7. Merims D., Shabtai H., Korczyn A.D., Peretz C., Weizman N., and Giladi N. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. J Neural Transm 111 (2004) 1453-1477
8. Bodis-Wollner I., and Yahr M.D. Measurements of visual evoked potentials in Parkinson's Disease. Brain 101 (1979) 667-671
9. Bodis-Wollner I., Mitra S., Bobak P., Guillory S., and Mylin L. Low frequency distortion in spatio-temporal threshold surface in Parkinson's Disease. Invest Ophthalmol Vis Sci 25 (1984) 313 [Suppl]
10. Onofrj M., and Bodis-Wollner I. Dopaminergic deficiency causes delayed visual evoked potentials in rats. Ann Neurol 11 (1982) 484-490
11. Onofrj M., Ghilardi M.F., Basciani M., and Gambi D. Visual evoked potentials in Parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. J Neurol Neurosurg Psychiatry 49 (1986) 1150-1159
12. Ghilardi M.F., Bodis-Wollner I., Onofrj M., Marx M.S., and Glover A.A. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain III (1988) 131-149
13. Ghilardi M.F., Chung E., Bodis-Wollner I., Dvorzniak M., Glover A.A., and Onofrj M. Systemic 1-Methyl, 4-Phenyl, 1-2-3-6 tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sci 43 (1988) 255-262
14. Bodis-Wollner I., and Onofrj M. Systems diseases and VEP diagnosis in neurology: changes due to synaptic malfunction. Ann N Y Acad Sci 388 (1982) 327-348
15. Bodis-Wollner I., and Onofrj M. Visual system in Parkinson's Disease. In: Yarh M.D., and Bergmann K.J. (Eds). Advances in Neurology vol. 45 (1986) 323-327
16. Matsui H., Udaka F., Tamura A., Oda M., Kubori T., Nishinaka K., et al. The relation between visual hallucinations and visual evoked potential in Parkinson's disease. Clin Neuropharmacol 28 2 (2005) 79-82
17. Harnois C., and Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 31 (1990) 2473-2475
18. Maurage C.A., Ruchoux M.M., de Vos R., Surguchov A., and Destee A. Retinal involvement in dementia with Lewy bodies: a clue to hallucinations. Ann Neurol 54 (2003) 542-547
19. Diedrich N.J., Goetz C.G., Raman R., Pappert E.J., Leurgans S., and Piery V. Poor visual discrimination and visual hallucinations in Parkinson's Disease. Clin Neuropharmacol 21 5 (1998) 289-295
20. Pieri V., Diedrich N.J., Raman R., and Goetz C.G. Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci 172 (2000) 7-11
21. Büttner T., Muller T., and Kuhn W. Effects of apomorphine on visual functions in Parkinson's Disease. J Neural Transm 107 (2000) 87-94
22. Graham J.M., Grünewald R.A., and Sagar H.J. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 63 4 (Oct 1997) 434-440
23. Arnulf I., Bonnet A.M., Damier P., Bejjani B.P., Seilhean D., Derenne J.P., et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 55 2 (2000 (Jul 25)) 281-288
24. Fenelon G., Mahieux F., Huon R., and Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123 Pt 4 (2000 (Apr)) 733-745
25. Ball B. De l'insanité dans la paralysie agitante. Encéphale 2 (1882) 22-32
26. Parant V. La paralysie agitante examinée comme cause de folie. Ann Med Psychol (Paris) 10 (1883) 45-63
27. Williams D., and Lees A. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 4 (2005) 605-610
28. Porteous H.B., and Ross D.N. Mental symptoms in parkinsonism following benzhexolhydrochloride therapy. Br Med J 2 (1956) 138-140
29. Celesia G.G., and Barr A.N. Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol 23 3 (Sep 1970) 193-200
30. Damasio A.R., Lobo-Antunes J., and Macedo C. Psychiatric aspects in Parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry 34 5 (Oct 1971) 502-507
31. Sacks O.W., Kohl M.S., Messeloff C.R., and Schwatz W.F. Effects of levodopa in parkinsonian patients with dementia. Neurology 22 (1972) 516-519
32. Sweet R.D., McDowell F.H., Feigenson J.S., Loranger A.W., and Goodell H. Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 26 4 (1976 (Apr)) 305-310
33. Goetz C.G., Tanner C.M., and Klawans H.L. Pharmacology of hallucinations induced by long term drug therapy. Am J Psychiatry 139 (1982) 494-497
34. Rondot P., De Recondo J., Coignet A., and Zeigler M. Mental disorder in Parkinson's disease after treatment with L-dopa. Adv Neurol 40 (1984) 259-269
35. Papapetropoulos S., Argyriou A.A., and Ellul J. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol 252 10 (2005) 1223-1228
36. Moskovitz C., Moses H., and Klawans H.L. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 135 (1978) 669-675
37. Factor S.A., McAlarney T., Sanchez-Ramos J.R., and Weiner W.J. Sleep disorders and sleep effect in Parkinson' disease. Mov Disord 5 4 (1990) 280-285
38. Pappert E.J., Goetz C.G., Niederman F.G., Raman R., and Leurgans S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 14 1 (1999 (Jan)) 117-121
39. Schenck C.H., Bundlie S.R., Ettinger M.G., and Mahowald M.W. Chronic behavioural disorders of human REM sleep: a new category of parasomnia. Sleep 9 (1986) 293-308
40. Nomura T., Inoue Y., Mitani H., Kawahara R., Myake M., and Nakashima K. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease. Mov Disord 18 7 (2003) 812-817
41. Pacchetti C., Manni R., Zangaglia R., Mancini F., Marchioni E., Tassorelli C., et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 20 11 (2005 (Nov)) 1439-1448
42. Comella C.L., Tanner C.M., and Ristanovic R.K. Polysomnographic sleep measures in Parkinson's Disease patients with treatment induced hallucinations. Ann Neurol 34 (1993) 710-714
43. Onofrj M., Luciano A.L., Thomas A., Iacono D., and D'Andreamatteo G. Mirtazapine induces RBD in Parkinson. Neurology 60 (2003) 113-115
44. Takata K., Inoue Y., Hazama H., and Fukuma E. Night-time hypnopompic visual hallucinations related to REM sleep disorder. Psychiatry Clin Neurosci 52 2 (1998 (Apr)) 207-209
45. Onofrj M., Luciano A.L., Iacono D., Thomas A., Stocchi F., Papola F., et al. HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease. Mov Disord 18 3 (2003 (Mar)) 337-340
46. Husain A.M., Miller P.P., and Carwile S.T. Rem sleep behavior disorder: potential relationship to post-traumatic stress disorder. J Clin Neurophysiol 18 2 (2001 (Mar)) 148-157
47. Onofrj M., Thomas A., D'Andreamatteo G., Iacono D., Luciano A.L., Di Rollo A., et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurol Sci 23 Suppl 2 (2002 (Sep)) S91-S94
48. Onofrj M., Curatola L., Ferracci F., and Fulgente T. Narcolepsy associated with primary temporal lobe b-cells lymphoma in a HLA DR2 negative subject. J Neurol Neurosurg Psychiatry 55 (1992) 852-853
49. Present state examination (9th of interview schedule, May 1973) MRC Social Psychiatry Unit, Medical research council 209-13.
50. Hoehn M.M., and Yahr M.D. Parkinsonism: onset progression and mortality. Neurology 17 (1967) 427-442
51. Fahn S., and Elton R. Members of UPDRS Development Committee (1987) Unified Parkinson's Disease rating scale. In: Fahn S., Marsden C.D., Calne D.B., and Goldstein M. (Eds). Recent Developments in Parkinson's Disease vol. 2 (1987), Macmillan Health Care Information, Florham Park, NJ 153-163
52. Folstein N.F., Folstein S.E., and McHugh P.R. Mini-Mental State: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12 (1975) 189M-198M
53. de la Fuente-Fernández R., Schulzer M., Mak E., Calne D.B., and A. Jon Stoessl A.J. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. Brain 4 (2004) 888-899
54. Barnes J., and David A.S. Visual hallucinations in Parkinson's Disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 70 (2001) 727-733
55. Onofrj M., Thomas A., Bonanni L., Iacono D., and Gambi F. Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Psychiatry 2 (2002) 22-24 [Review series]
56. Harper R.W., and Knothe B.U. Coloured Lilliputian hallucinations with amantadine. Med J Aust 1 9 (1973 (Mar 3)) 444-445
57. Chan D., and Rossor M.N. "-but who is that on the other side of you?" Extracampine hallucinations revisited. Lancet 360 9350 (2002 (Dec 21-28)) 2064-2066
58. Ebersbach G. An artist's view of drug-induced hallucinosis. Mov Disord 18 7 (Jul 2003) 833-834
59. Poewe W. Psychosis in Parkinson's disease. Mov Disord 18 Suppl 6 (2003 (Sep)) S80-S87
60. Burke W. The neural basis of Charles Bonnet syndrome: a hypothesis. J Neurol Neurosurg Psychiatry 73 (2002) 535-541
61. Onofrj M. Disturbi Mentali nelle Sindromi Parkinsoniane (2003), Springer-Verlag Italia, Milano
62. Onofrj M., and Thomas A. Severe worsening of Parkinsonism in Lewy Body Dementia due to administration of Donepezil. Neurology 25;61 10 (2003) 1452
63. Lugaresi E., and Provini F. Agrypnia excitata: clinical features and pathophysiological implications. Sleep Med Rev 5 4 (2001) 313-322
64. Mahowald M.W., and Schenk C.H. Status dissociatus - a perspective on state of being. Sleep 14 1 (1991) 69-79
65. Jacob A., Prasad S., Boggild M., and Chandratre S. Charles Bonnet syndrome-elderly people and visual hallucinations. BMJ 328 7455 (2004 (Jun 26)) 1552-1554
66. Kolmel H.W. Peduncular hallucinations. J Neurol 238 8 (1991 (Dec)) 457-459
67. Schultze, and Melzack. Visual hallucinations and mental state: a study of 14 Charles Bonnet Syndrome hallucinations. J Nerv Ment Dis 181 (1993) 639-643
68. Teunisse R., Cruysberg J.R., Verbeek A., and Zitman F.G. The Charles Bonnet Syndrome: a large prospective study in the Netherlands. Br J Psychiatry 166 (1995) 234-257
69. de la Fuente Fernandez R., Lopez J., Rey del Corral P., and de la Iglesia Martinez F. Peduncular hallucinosis and right hemiparkinsonism caused by left mesencephalic infarction. J Neurol Neurosurg Psychiatry 57 7 (Jul 1994) 870
70. McKee A.C., Levine D.N., Kowall N.W., and Richardson Jr. E.P. Peduncular hallucinosis associated with isolated infarction of the substantia nigra pars reticulata. Ann Neurol 27 5 (1990 May) 500-504
71. Liedholm L.J., Anjegard I.M., de Flon P., and Smedby T. Two cases of peduncular hallucinosis. Vivid, colorful and dancing images and figures. Lakartidningen (1999 (Apr 7)) 96
72. Hobson J.A., Pace-Schott E.F., and Stickgold R. Dreaming and the brain: toward a cognitive neuroscience of conscious states. Behav Brain Sci 23 6 (2000 (Dec)) 793-842
73. Joel D. Mov Disord 16 3 (2001) 407-423